UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 21, 2022
Accession Number:
Submission Type:
CIK:
0001372514
Company Name:
KIORA PHARMACEUTICALS INC
File Number:
333-264641